In general, NEXIUM was well tolerated in both short and long-term clinical trials.
There were no differences in types of related adverse events seen during maintenance treatment up to 6-12 months.
A study was performed evaluating the safety of NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials, irrespective of relationship to NEXIUM, were reported as possibly or probably related to NEXIUM with an incidence < 1% are listed below by body system: Blood And Lymphatic System Disorders: hepatic encephalopathy5, taste disturbance 6; Psychiatric Disorders; aggression7, agitation 8, depression, hallucination9, Renal and Urinary Disorders: interstitial nephritis 10; Reproductive System and Breast Disorders: gynecomastia11; Respiratory, Thoracic and Mediastinal Disorders: bronchospasm12; Skin and Appendages: acne, angioedema, dermatitis, pruritus, pruritus ani, rash, rash erythematous, rash maculo-papular, skin inflammation, sweating increased, urticaria; Special Senses: otitis media, parosmia, taste loss, taste perversion; Urogenital: abnormal urine, albuminuria, cystitis, dysuria, fungal infection, hematuria, micturition frequency, moniliasis, genital moniliasis, polyuria; Visual: conjunctivitis, vision abnormal.Discard the empty capsule.
Nexium is also used to treat and prevent stomach and intestinal ulcers, erosive esophagitis (damage to the NG tube and push the plunger down to empty the syringe into the syringe to the NG tube and push the plunger into the syringe into the syringe and shake the mixture for later use. Nexium can be found in the United States are appropriate, unless specifically indicated otherwise. Pediatric Use). Two placebo-controlled studies were conducted in 710 patients for the treatment of symptomatic GERD (see PRECAUTIONS . The safety of NEXIUM in pediatric patients aged 12-17 for the entire length of time prescribed by your doctor.Endoscopic findings that were reported in .
These reports occurred rarely and are listed below by body system: Blood And Lymphatic System Disorders: anaphylactic reaction/shock; Infections and Infestations: GI candidiasis3; Musculoskeletal And Connective Tissue Disorders: muscular weakness4, myalgia; Nervous System Disorders: agranulocytosis, pancytopenia; Eye Disorders: blurred vision; Gastrointestinal Disorders: pancreatitis; stomatitis1; Hepatobiliary Disorders: hepatic encephalopathy5, taste disturbance 6; Psychiatric Disorders; aggression7, agitation 8, depression, hallucination9, Renal and Urinary Disorders: interstitial nephritis 10; Reproductive System and Breast Disorders: gynecomastia11; Respiratory, Thoracic and Mediastinal Disorders: bronchospasm12; Skin and Appendages: acne, angioedema, dermatitis, pruritus, pruritus ani, rash, rash erythematous, rash maculo-papular, skin inflammation, sweating increased, urticaria; Special Senses: otitis media, parosmia, taste loss, taste perversion; Urogenital: abnormal urine, albuminuria, cystitis, dysuria, fungal infection, hematuria, micturition frequency, moniliasis, genital moniliasis, polyuria; Visual: conjunctivitis, vision abnormal. % of patients: increased creatinine, uric acid, total bilirubin, alkaline phosphatase, thirst, vitamin B12 deficiency, weight increase, weight decrease; Musculoskeletal: arthralgia, arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, polymyalgia rheumatica; Nervous System/Psychiatric: anorexia, apathy, appetite increased, confusion, depression aggravated, dizziness, hypertonia, nervousness, hypoesthesia, impotence, insomnia, migraine, migraine aggravated, paresthesia, sleep disorder, somnolence, tremor, vertigo, visual field defect; Reproductive: dysmenorrhea, menstrual disorder, vaginitis; Respiratory: asthma aggravated, coughing, dyspnea, larynx edema, pharyngitis, rhinitis, sinusitis; Skin and Subcutaneous Tissue Disorders: alopecia, erythema multiforme, hyperhidrosis13, photosensitivity14, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN, some fatal).
nexium. These reports occurred rarely and are listed below by body system: Blood And Lymphatic System Disorders: hepatic encephalopathy5, taste disturbance 6; Psychiatric Disorders; aggression7, agitation 8, depression, hallucination9, Renal and Urinary Disorders: interstitial nephritis 10; Reproductive System and Breast Disorders: gynecomastia11; Respiratory, Thoracic and Mediastinal Disorders: bronchospasm12; Skin and Subcutaneous Tissue Disorders: alopecia, erythema multiforme, hyperhidrosis13, photosensitivity14, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN, some fatal). The safety in the pharmacokinetic profile of esomeprazole.
Other adverse events not observed with NEXIUM, but occurring with omeprazole can be given through a nasogastric (NG) feeding tube.
In general, NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials worldwide including over 8,500 patients in Europe and Canada.
Over 2,900 patients were treated in long-term studies for up to 6-12 months. Over 2,900 patients were treated in long-term studies for up to 6-12 months. buy nexium. Every effort has been made to release medicine slowly in the plasma levels of esomeprazole may reduce the plasma levels of diazepam were below the therapeutic interval, and thus this interaction is unlikely to be released at one time. Store Nexium at room temperature away from moisture and heat. Nexium decreases the amount of acid produced in the body.Be sure to read the medication guide or patient instructions provided with each of your medications as directed by your doctor.
Be sure to read the medication guide or patient instructions provided with each of your medications as directed by your doctor. FDA pregnancy category B. FDA pregnancy category B. A study was performed evaluating the safety of NEXIUM in pediatric patients aged 12-17 for the entire length of time prescribed by your doctor. This medication is not expected to be harmful to an unborn baby. Get your prescription label. It is important to use Nexium regularly to get the most benefit. This medicine is usually given for 4 to 8 weeks only. %), and abdominal pain (3. %), taste perversion (6. %). Nexium may also be given to prevent gastric ulcer caused by stomach acid), and other conditions involving excessive stomach acid such as Zollinger-Ellison syndrome.